GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » 3-Year FCF Growth Rate

Beijing Science Sun Pharmaceutical Co (SZSE:300485) 3-Year FCF Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co 3-Year FCF Growth Rate?

Beijing Science Sun Pharmaceutical Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥0.07.

During the past 12 months, Beijing Science Sun Pharmaceutical Co's average Free Cash Flow per Share Growth Rate was -82.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Beijing Science Sun Pharmaceutical Co was 23.90% per year. The lowest was -48.10% per year. And the median was -2.70% per year.


Competitive Comparison of Beijing Science Sun Pharmaceutical Co's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Science Sun Pharmaceutical Co's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Science Sun Pharmaceutical Co's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Science Sun Pharmaceutical Co's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Beijing Science Sun Pharmaceutical Co's 3-Year FCF Growth Rate falls into.



Beijing Science Sun Pharmaceutical Co 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Beijing Science Sun Pharmaceutical Co  (SZSE:300485) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Beijing Science Sun Pharmaceutical Co 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Beijing Science Sun Pharmaceutical Co's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Science Sun Pharmaceutical Co (SZSE:300485) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176
Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.
Executives
Ma Li Directors, executives
Kong Shuang Quan Executives
Li Jian Hua Director
Ma Biao Directors, executives
Li Zhi Bing Supervisors
Zhang Fan Executives

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Headlines

No Headlines